Discovery of novel orally active ureido NPY Y5 receptor antagonists
摘要:
We have derived a novel series of neuropeptide Y (NPY) Y5 receptor antagonists from the biphenylurea 3. Cyclohexylurea 21c, a member of the series, is a potent NPY Y5 receptor antagonist that exhibits excellent pharmacokinetic parameters in rats and dogs. On chronic oral administration to diet-induced obese rats, 21c displayed an anti-obesity profile, causing a modest reduction in food intake, a significant decrease in body weight gain, a decrease in adipose mass, and an increase in lean tissue mass. (C) 2007 Elsevier Ltd. All rights reserved.
Discovery of novel orally active ureido NPY Y5 receptor antagonists
摘要:
We have derived a novel series of neuropeptide Y (NPY) Y5 receptor antagonists from the biphenylurea 3. Cyclohexylurea 21c, a member of the series, is a potent NPY Y5 receptor antagonist that exhibits excellent pharmacokinetic parameters in rats and dogs. On chronic oral administration to diet-induced obese rats, 21c displayed an anti-obesity profile, causing a modest reduction in food intake, a significant decrease in body weight gain, a decrease in adipose mass, and an increase in lean tissue mass. (C) 2007 Elsevier Ltd. All rights reserved.
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
申请人:——
公开号:US20040242636A1
公开(公告)日:2004-12-02
The present invention relates to novel compounds, their use for inhibiting post prolin/analine-cleaving proteases, such as serine proteases, such as dipeptidyl peptidases, such as dipeptidyl peptidase IV (DPP-IV), and to methods for their production and their therapeutic utility.
FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP1399433A2
公开(公告)日:2004-03-24
US7183290B2
申请人:——
公开号:US7183290B2
公开(公告)日:2007-02-27
US7304076B2
申请人:——
公开号:US7304076B2
公开(公告)日:2007-12-04
[EN] FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS<br/>[FR] FLUOROPYRROLIDINES INHIBITRICES DE LA DIPEPTIDYL PEPTIDASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003002553A2
公开(公告)日:2003-01-09
The present invention relates to novel compounds of following formulae (I)-(VI) their use for inhibiting post prolin/analine-cleaving proteases, such as serine proteases, such as dipeptidyl peptidases, such as dipeptidyl peptidase IV (DPP-IV), and to methods for their production and their therapeutic utility.